ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Inflammasome, Unfolded Protein Response, and T Cell Immunity in DAIH.

    A. Arterbery,1 M. Martinez,3 S. Lobritto,3 Y. Avitzur,2 U. Ekong.1

    1Ped Gastro. and Hep., Yale University, New Haven, CT; 2Gastro., Hep., and Nutr., Hospital for Sick Children, Toronto, ON, Canada; 3Ped. Gastro., Hep., and Nutr., Columbia University, New York, NY

    Background: Regulatory T cells (Tregs) of patients with de novo autoimmune hepatitis (DAIH) secrete IL-17A & IFN-g; display TH1 & TH17 pehnotypes & are functionally…
  • 2017 American Transplant Congress

    Circulating Donor-Specific Memory B Cells (mBc) Discriminates Kidney Transplant Patients with Histological Lesions of ABMR in Absence of Circulating DSA.

    S. Luque,2 M. Lúcia,4 M. Jarque,2 E. Crespo,2 E. Melilli,1 J. Martorell,3 J. Cruzado,1,2 J. Torras,1,2 J. Grinyó,1,2 O. Bestard.1,2

    1Kidney Transplant Unit, Nephrology Department, Bellvitge University Hospital, Barcelona, Catalunya, Spain; 2Experimental Nephrology Laboratory, IDIBELL, Barcelona, Catalunya, Spain; 3Immunogenetics Laboratory, Hospital Clínic, Barcelona, Catalunya, Spain; 4Transplant Immunology, School of Medicine, Stanford

    Chronic (c)ABMR is a main cause of immune-mediated kidney allograft loss. For its diagnosis, specific histological lesions together with presence of circulating donor-specific alloantibodies (DSA)…
  • 2017 American Transplant Congress

    The Beneficial Effect of Janus Kinase 3 Inhibitor on Transplanted Islet via Protection from Oxidative Stress-Induced β Cell Death.

    S.-J. Kang,1,2,3,4 H. Chung,1,2,3,4 S. Lee,1,2,3,4 J.-S. Shin,1,3,5 H.-J. Kim,1,2,3,4 J.-M. Kim,1,3,5 B.-H. Min,1,3,5 S. Choi,1,2,3,4 C.-G. Park.1,2,3,4,5

    1Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul, Korea; 2Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; 3Xenotransplantation Research Center, Seoul National University College of Medicine, Seoul, Korea; 4Department of Biomedical Sciences, Seoul National University, Seoul, Korea; 5Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul, Korea

    Janus kinase 3 (JAK3) is one of the molecules that make up the JAK-STAT signaling pathway that regulates numerous 40 cytokines. Thus, this cascade can…
  • 2017 American Transplant Congress

    The Impact of Belatacept on Anti-HLA Antibodies of Highly Sensitized Kidney Transplant Recipients.

    R. Parsons, H. Decker, T. Pearson, C. Larsen, R. Bray, H. Gebel.

    Emory Transplant Center, Atlanta, GA

    Background: Anti-HLA antibodies often prevent successful organ transplantation. Interestingly, belatacept limits de novo antibody production within the germinal center, but its impact on long-lived plasma…
  • 2017 American Transplant Congress

    Women in the United States Receive More Resections and Ablations for Hepatocellular Carcinoma Than Men.

    L. Sobotka,1 A. Hinton,2 L. Conteh.1

    1The Ohio State Wexner Medical Center, Columbus; 2The Ohio State University, Columbus

    Background: Previous studies have shown conflicting data regarding gender disparities in the treatment of hepatocellular carcinoma. Several studies have suggested that men are more likely…
  • 2017 American Transplant Congress

    Serum AFP Greater Than 200 ng/ml as a Predictor for Low Survival in Patients with Hepatocelullar Carcinoma Recurrence in a Brazilian Multicentric Study.

    I. Boin,1 M. Possatto,1 E. Ataide,1 R. Silva,2 R. Silva,2 H. Felicio,2 L. Amado,3 A. Lima,3 T. Seva-Pereira.1

    1Unit of Liver Transplantation, State University of Campinas, Campinas, SP, Brazil; 2Digestive Surgery - Liver Transplantation, Faculty of Medicine- São Jose do Rio Preto, Rio Preto, SP, Brazil; 3Digestive Surgery - Liver Transplantation, Faculty of Medicine, Federal University of Minas Gerais, Minas Gerais, Brazil

    Introduction: Liver transplantation (LT) is the only potential curative treatment for hepatocellular carcinoma (HCC) with recurrence (HCC-R) diagnosed in 16%. Aim: The objective of this…
  • « Previous Page
  • 1
  • …
  • 179
  • 180
  • 181

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences